1. Giulidori, P., Galli-Kienle, M., Catto, E., & Stramentinoli, G. (1984). Transmethylation, trans-sulfuration, and aminopropylation reactions of S-adenosyl-l-methionine in vivo. Journal of Biological Chemistry, 259, 4205–4211.
2. Winkler, W. C., Nahvi, A., Sudarsan, N., Barrick, J. E., & Breaker, R. R. (2003). An mRNA structure that controls gene expression by binding S-adenosylmethionine. Nature Structural Biology, 10, 701–707.
3. Lieber, C. S. (1999). Role of S-adenosyl-l-methionine in the treatment of liver diseases. Journal of Hepatology, 30, 1155–1159.
4. Cimino, M., Vantini, G., Algeri, S., Curatola, G., Pezzoli, C., & Stramentinoli, G. (1984). Age-related modification of dopaminergic and beta-adrenergic receptor system: restoration to normal activity by modifying membrane fluidity with S-adenosyl-l-methionine. Life Sciences, 34, 2029–2039.
5. Barcelo, H. A., Wiemeyer, J. C., Sagasta, C. L., Macias, M., & Barreira, J. C. (1990). Experimental osteoarthritis and its course when treated with S-adenosyl-l-methionine. Revista Clínica Española, 187, 74–78.